|
1
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wiggans RG, Woolley PV, Smythe T, Hoth D,
Macdonald JS, Green L and Schein PS: Phase-II tlial of tamoxifen in
advanced breast cancer. Cancer Chemother Pharmacol. 3:45–48. 1979.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carey LA, Dees EC, Sawyer L, Gatti L,
Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML and Perou
CM: The triple negative paradox: Primary tumor chemosensitivity of
breast cancer subtypes. Clin Cancer Res. 13:2329–2334. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Higgins MJ and Baselga J: Targeted
therapies for breast cancer. J Clin Invest. 121:3797–3803. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lehmann BD, Bauer JA, Chen X, Sanders ME,
Chakravarthy AB, Shyr Y and Pietenpol JA: Identification of human
triple-negative breast cancer subtypes and preclinical models for
selection of targeted therapies. J Clin Invest. 121:2750–2767.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fisher B, Costantino JP, Wickerham DL,
Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins
JN, Margolese RG, et al: Tamoxifen for prevention of breast cancer:
Report of the national surgical adjuvant breast and bowel project
P-1 study. J Natl Cancer Inst. 97:1652–1662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Seth P, Krop I, Porter D and Polyak K:
Novel estrogen and tamoxifen induced genes identified by SAGE
(Serial Analysis of Gene Expression). Oncogene. 21:836–843. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jaiyesimi IA, Buzdar AU, Decker DA and
Hortobagyi GN: Use of tamoxifen for breast cancer: Twenty-eight
years later. J Clin Oncol. 13:513–529. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ross RJ, Weiner MM and Lin H: PIWI
proteins and PIWI-interacting RNAs in the soma. Nature.
505:353–359. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meister G: Argonaute proteins: Functional
insights and emerging roles. Nat Rev Genet. 14:447–459. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suzuki R, Honda S and Kirino Y: PIWI
expression and function in cancer. Front Genet. 3:2042012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cox DN, Chao A, Baker J, Chang L, Qiao D
and Lin H: A novel class of evolutionarily conserved genes defined
by piwi are essential for stem cell self-renewal. Genes Dev.
12:3715–3727. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deng W and Lin H: miwi, a murine
homolog of piwi, encodes a cytoplasmic protein essential for
spermatogenesis. Dev Cell. 2:819–830. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sasaki T, Shiohama A, Minoshima S and
Shimizu N: Identification of eight members of the argonaute family
in the human genome. Genomics. 82:323–330. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thomson T and Lin H: The biogenesis and
function PIWI proteins and piRNAs: Progress and prospect. Annu Rev
Cell Dev Biol. 25:355–376. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qiao D, Zeeman AM, Deng W, Looijenga LH
and Lin H: Molecular characterization of hiwi, a human
member of the piwi gene family whose overexpression is
correlated to seminomas. Oncogene. 21:3988–3999. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He G, Chen L, Ye Y, Xiao Y, Hua K,
Jarjoura D, Nakano T, Barsky SH, Shen R and Gao JX: Piwil2
expressed in various stages of cervical neoplasia is a potential
complementary marker for p16INK4a. Am J Transl Res.
2:156–169. 2010.PubMed/NCBI
|
|
18
|
Lee JH, Jung C, Javadian-Elyaderani P,
Schweyer S, Schütte D, Shoukier M, Karimi-Busheri F, Weinfeld M,
Rasouli-Nia A, Hengstler JG, et al: Pathways of proliferation and
antiapoptosis driven in breast cancer stem cells by stem cell
protein piwil2. Cancer Res. 70:4569–4579. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu W, Jiang X and Zhang Z: Expression of
PSCA, PIWIL1, and TBX2 in endometrial adenocarcinoma. Onkologie.
33:241–245. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu Y, Zhang K, Li C, Yao Y, Tao D, Liu Y,
Zhang S and Ma Y: Piwil2 suppresses p53 by inducing phosphorylation
of signal transducer and activator of transcription 3 in tumor
cells. PLoS One. 7:e309992012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Z, Liu N, Shi S, Liu S and Lin H: The
role of PIWIL4, an argonaute family protein, in breast cancer. J
Biol Chem. 291:10646–10658. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sugimoto K, Kage H, Aki N, Sano A,
Kitagawa H, Nagase T, Yatomi Y, Ohishi N and Takai D: The induction
of H3K9 methylation by PIWIL4 at the p16Ink4a locus. Biochem
Biophys Res Commun. 359:497–502. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He X, Chen X, Zhang X, Duan X, Pan T, Hu
Q, Zhang Y, Zhong F, Liu J, Zhang H, et al: An Lnc RNA
(GAS5)/SnoRNA-derived piRNA induces activation of TRAIL gene by
site-specifically recruiting MLL/COMPASS-like complexes. Nucleic
Acids Res. 43:3712–3725. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu D, Fu H, Zhou H, Su J, Zhang F and Shen
J: Effects of Novel ncRNA molecules, p15-piRNAs, on the methylation
of DNA and histone H3 of the CDKN2B promoter region in U937 cells.
J Cell Biochem. 116:2744–2754. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhong F, Zhou N, Wu K, Guo Y, Tan W, Zhang
H, Zhang X, Geng G, Pan T, Luo H, et al: A SnoRNA-derived piRNA
interacts with human interleukin-4 pre-mRNA and induces its decay
in nuclear exosomes. Nucleic Acids Res. 43:10474–10491.
2015.PubMed/NCBI
|
|
26
|
Jiang S, Zhao L, Lu Y, Wang M, Chen Y, Tao
D, Liu Y, Sun H, Zhang S and Ma Y: Piwil2 inhibits keratin 8
degradation through promoting p38-induced phosphorylation to resist
Fas-mediated apoptosis. Mol Cell Biol. 34:3928–3938. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Krishnan P, Ghosh S, Graham K, Mackey JR,
Kovalchuk O and Damaraju S: Piwi-interacting RNAs and PIWI genes as
novel prognostic markers for breast cancer. Oncotarget.
7:37944–37956. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Horwitz KB, Koseki Y and McGuire WL:
Estrogen control of progesterone receptor in human breast cancer:
Role of estradiol and antiestrogen. Endocrinology. 103:1742–1751.
1978. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Henry JA, Nicholson S, Hennessy C, Lennard
TW, May FE and Westley BR: Expression of the oestrogen regulated
pNR-2 mRNA in human breast cancer: Relation to oestrogen receptor
mRNA levels and response to tamoxifen therapy. Br J Cancer.
61:32–38. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Frasor J, Danes JM, Komm B, Chang KC,
Lyttle CR and Katzenellenbogen BS: Profiling of estrogen up- and
down-regulated gene expression in human breast cancer cells:
Insights into gene networks and pathways underlying estrogenic
control of proliferation and cell phenotype. Endocrinology.
144:4562–4574. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Journé F, Body JJ, Leclercq G, Nonclercq D
and Laurent G: Estrogen responsiveness of IBEP-2, a new human cell
line derived from breast carcinoma. Breast Cancer Res Treat.
86:39–53. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rae JM, Johnson MD, Scheys JO, Cordero KE,
Larios JM and Lippman ME: GREB 1 is a critical regulator of hormone
dependent breast cancer growth. Breast Cancer Res Treat.
92:141–149. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jung JW, Park SB, Lee SJ, Seo MS, Trosko
JE and Kang KS: Metformin represses self-renewal of the human
breast carcinoma stem cells via inhibition of estrogen
receptor-mediated OCT4 expression. PLoS One. 6:e280682011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang C, Mayer JA, Mazumdar A, Fertuck K,
Kim H, Brown M and Brown PH: Estrogen induces c-myc gene
expression via an upstream enhancer activated by the estrogen
receptor and the AP-1 transcription factor. Mol Endocrinol.
25:1527–1538. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun Y, Wang Y, Fan C, Gao P, Wang X, Wei G
and Wei J: Estrogen promotes stemness and invasiveness of
ER-positive breast cancer cells through Gli1 activation. Mol
Cancer. 13:1372014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Van Zijl C, Lottering ML, Steffens F and
Joubert A: In vitro effects of 2-methoxyestradiol on MCF-12A and
MCF-7 cell growth, morphology and mitotic spindle formation. Cell
Biochem Funct. 26:632–642. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Treeck O, Lattrich C, Springwald A and
Ortmann O: Estrogen receptor beta exerts growth-inhibitory effects
on human mammary epithelial cells. Breast Cancer Res Treat.
120:557–565. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Paruthiyil S, Parmar H, Kerekatte V, Cunha
GR, Firestone GL and Leitman DC: Estrogen receptor beta inhibits
human breast cancer cell proliferation and tumor formation by
causing a G2 cell cycle arrest. Cancer Res. 64:423–428. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Prest SJ, May FE and Westley BR: The
estrogen-regulated protein, TFF1, stimulates migration of human
breast cancer cells. FASEB J. 16:592–594. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang X, Nakamura M, Mori I, Takeda K,
Nakamura Y, Utsunomiya H, Yoshimura G, Sakurai T and Kakudo K:
Calcitonin receptor gene and breast cancer: Quantitative analysis
with laser capture microdissection. Breast Cancer Res Treat.
83:109–117. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Arnold A and Papanikolaou A: Cyclin D1 in
breast cancer pathogenesis. J Clin Oncol. 23:4215–4224. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Roy PG and Thompson AM: Cyclin D1 and
breast cancer. Breast. 15:718–727. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mathew AC, Rajah TT, Hurt GM, Abidi Abbas
SM, Dmytryk JJ and Pento JT: Influence of antiestrogens on the
migration of breast cancer cells using an in vitro wound model.
Clin Exp Metastasis. 15:393–399. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Malek D, Gust R and Kleuser B:
17-Beta-estradiol inhibits transforming-growth-factor-beta-induced
MCF-7 cell migration by Smad3-repression. Eur J Pharmacol.
534:39–47. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zheng S, Huang J, Zhou K, Zhang C, Xiang
Q, Tan Z, Wang T and Fu X: 17β-Estradiol enhances breast cancer
cell motility and invasion via extra-nuclear activation of
actin-binding protein ezrin. PLoS One. 6:e224392011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li CL, Yang D, Cao X, Wang F, Hong DY,
Wang J, Shen XC and Chen Y: Fibronectin induces
epithelial-mesenchymal transition in human breast cancer MCF-7
cells via activation of calpain. Oncol Lett. 13:3889–3895. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Park SJ, Kim JG, Kim ND, Yang K, Shim JW
and Heo K: Estradiol, TGF-β1 and hypoxia promote breast cancer
stemness and EMT-mediated breast cancer migration. Oncol Lett.
11:1895–1902. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mendez MG, Kojima S and Goldman RD:
Vimentin induces changes in cell shape, motility, and adhesion
during the epithelial to mesenchymal transition. FASEB J.
24:1838–1851. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liu CY, Lin HH, Tang MJ and Wang YK:
Vimentin contributes to epithelial-mesenchymal transition cancer
cell mechanics by mediating cytoskeletal organization and focal
adhesion maturation. Oncotarget. 6:15966–15983. 2015.PubMed/NCBI
|
|
51
|
Gross JM and Yee D: How does the estrogen
receptor work? Breast Cancer Res. 4:62–64. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Dahlman-Wright K, Qiao Y, Jonsson P,
Gustafsson JÅ, Williams C and Zhao C: Interplay between AP-1 and
estrogen receptor α in regulating gene expression and proliferation
networks in breast cancer cells. Carcinogenesis. 33:1684–1691.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dong J, Tsai-Morris CH and Dufau ML: A
novel estradiol/estrogen receptor alpha-dependent transcriptional
mechanism controls expression of the human prolactin receptor. J
Biol Chem. 281:18825–18836. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kalet BT, Anglin SR, Handschy A,
O'Donoghue LE, Halsey C, Chubb L, Korch C and Duval DL:
Transcription factor Ets1 cooperates with estrogen receptor α to
stimulate estradiol-dependent growth in breast cancer cells and
tumors. PLoS One. 8:e688152013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Simoncini T, Mannella P, Fornari L, Caruso
A, Varone G and Genazzani AR: Genomic and non-genomic effects of
estrogens on endothelial cells. Steroids. 69:537–542. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Huan J, Wang L, Xing L, Qin X, Feng L, Pan
X and Zhu L: Insights into significant pathways and gene
interaction networks underlying breast cancer cell line MCF-7
treated with 17β-Estradiol (E2). Gene. 533:346–355. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Raffo D, Pontiggia O, de Kier Joffé Bal E
and Simian M: Non-genomic actions of estradiol and 4-OH-tamoxifen
on murine breast cancer cells. Oncol Rep. 33:439–447. 2015.
View Article : Google Scholar : PubMed/NCBI
|
